Advances in Therapy

, Volume 24, Issue 4, pp 741–747 | Cite as

Levels of serum and cerebrospinal fluid soluble CD27 in the diagnosis of leptomeningeal involvement of hematolymphoid malignancies

  • Ismail Oguz Kara
  • Berksoy Sahin
  • Ramazan Gunesacar


Reportedly, soluble CD27 (sCD27) is a sensitive and specific marker for leptomeningeal involvement (LI) of CD27-expressing lymphoproliferations, such as B-cell non-Hodgkin’s lymphoma and chronic B-lymphocytic leukemia. On morphologic analysis of cerebrospinal fluid (CSF), one third of patients suspected of LI have false negatives, so a diagnostic marker for LI in B-cell non-Hodgkin’s lymphoma or B-lymphocytic leukemia would be extremely valuable. sCD27 was detected in the serum and CSF samples from 35 selected patients in whom 18 cases of acute lymphoblastic leukemia (ALL) (3 with LI), 7 of non-Hodgkin’s lymphoma, and 5 of acute myelogenous leukemia (3 with LI) were submitted for (immuno)morphologic detection of malignant cells and intrathecal therapy, along with samples from 5 control patients (2 submitted for epidural hemorrhage, 3 for lumbar disc protrusion). Concentrations of CSF-sCD27 were determined by enzyme-linked immunosorbent assay (PeliKine Compact Human Soluble CD27 ELISA Kit, Cat. No. M1960; Research Diagnostics Inc., Concord, Mass). The cutoff value was 350 U/mL. Serum and CSF-sCD27 concentrations above the cutoff value were not detected. Although it is unlikely that LI would be present in patients with chronic lymphoproliferation who have normal sCD27 concentrations in CSF samples, the determination of CSF-sCD27 is not sufficiently specific to allow it to serve as a reliable tumor marker.


sCD27 acute leukemia central nervous system lymphoma 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Glass JP, Melamed M, Chernik NL, Posner JB. Malignant cells in cerebrospinal fluid (CSF): the meaning of a positive CSF cytology.Neurology. 1979;29:1369–1375.PubMedGoogle Scholar
  2. 2.
    Hovestadt A, Henzen-Logmans SC, Vecht CJ. Immunohistochemical analysis of the cerebrospinal fluid for carcinomatous and lymphomatous leptomeningitis.Br J Cancer. 1991;62:653–654.Google Scholar
  3. 3.
    Weller M, Stevens A, Sommer N, Schabet M, Wietholter H. Humoral CSF parameters in the differential diagnosis of hematological CNS neoplasia.Acta Neurol Scand. 1992;86:129–133.PubMedGoogle Scholar
  4. 4.
    Twijnstra A, Ongerboer de Visser BW, van Zanten AP. Diagnosis of leptomeningeal metastasis.Clin Neurol Neurosurg. 1987;89:79–85.PubMedCrossRefGoogle Scholar
  5. 5.
    Jeffery GM, Frampton CM, Legge HM, Hart DN. Cerebrospinal fluid β-microglobulin levels in meningeal involvement by malignancy.Pathology. 1990;22:20–23.PubMedCrossRefGoogle Scholar
  6. 6.
    Stucki A, Cordey A, Monai N, de Flaugergues J, Schapira M, Spertini O. Cleaved L-selectin concentrations in meningeal leukemia.Lancet. 1995;345:286–289.PubMedCrossRefGoogle Scholar
  7. 7.
    Finn WG, Peterson LC, James C, Goolsby CL. Enhanced detection of malignant lymphoma in the cerebrospinal fluid by multiparameter flow cytometry.Am J Clin Pathol. 1998;110:341–346.PubMedGoogle Scholar
  8. 8.
    Rhodes CH, Glantz MJ, Glantz L, et al. A comparison of polymerase chain reaction examination of cerebrospinal fluid and conventional cytology in the diagnosis of lymphomatous meningitis.Cancer. 1996;77:543–548.PubMedCrossRefGoogle Scholar
  9. 9.
    van Oostenbrugge RJ, Hopman AH, Lenders MH, et al. Detection of malignant cells in cerebrospinal fluid using fluorescence in situ hybridization.J Neuropathol Exp Neurol. 1997;56:743–748.PubMedCrossRefGoogle Scholar
  10. 10.
    Widney D, Gundapp G, Said JW, et al. Aberrant expression of CD27 and soluble CD27 (sCD27) in HIV infection and in AIDS-associated lymphoma.Clin Immunol. 1999;93:114–123.PubMedCrossRefGoogle Scholar
  11. 11.
    Hintzen RQ, de Jong R, Hack CE, et al. A soluble form of the human T cell differentiation antigen CD27 is released after triggering of the TCR/CD3 complex.J Immunol. 1991;147:29–35.PubMedGoogle Scholar
  12. 12.
    Kersten MJ, Evers LM, Dellemijn PLI, et al. Elevation of cerebrospinal fluid soluble CD27 levels in patients with meningeal localization of lymphoid malignancies.Blood. 1996;87:1958–1989.Google Scholar
  13. 13.
    Hintzen RQ, van Lier RAW, Kuijpers KC, et al. Elevated levels of a soluble form of the T cell activation antigen CD27 in cerebrospinal fluid of multiple sclerosis patients.J Neuroimmunol. 1991;35:211–217.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science and Business Media and LLC 2007

Authors and Affiliations

  • Ismail Oguz Kara
    • 1
  • Berksoy Sahin
    • 1
  • Ramazan Gunesacar
    • 2
  1. 1.Department of Medical OncologyCukurova University Faculty of MedicineAdanaTurkey
  2. 2.Department of Rheumatology-ImmunologyCukurova University Faculty of MedicineAdanaTurkey

Personalised recommendations